12 pending office actions • 9 clients
| App # | Title | Client | Examiner | Art Unit | Status | Filed |
|---|---|---|---|---|---|---|
| 19329207 | Untitled | Surface Ophthalmics, Inc. | MILLER, DALE R | 1693 | Non-Final OA | |
| 29971079 | HUB FOR MINI COMPUTER | Sariana LLC | FAST HORSE, MARIE D | 2962 | Non-Final OA | Oct 31, 2024 |
| 18705554 | METHOD OF MOUNTING A BIOLOGICAL SAMPLE ON A SURFACE | Resolve Biosciences GmbH | KASAYAN, KATRIEL BARCELLANO | 1634 | Non-Final OA | Apr 27, 2024 |
| 18578549 | METHODS FOR TREATING CORONAVIRUS INFECTION | BIOGENESYS, INC. | ROBINSON, MIKHAIL O'DONNEL | 1627 | Non-Final OA | Jan 11, 2024 |
| 18263637 | SOLUBLE CHELATOR FOR TARGETING RECOMBINANT PROTEINS | Cube Biotech GmbH | HOU, FRANK S | 1692 | Non-Final OA | Jul 31, 2023 |
| 18258297 | IMPROVED PATCH | Apaloo GmbH | ARNOLD, ERNST V | 1613 | Final Rejection | Jun 19, 2023 |
| 18131841 | PHARMACEUTICAL KITS AND THEIR USE FOR TREATING DRY EYE DISEASE | Surface Ophthalmics, Inc. | WESTERBERG, NISSA M | 1618 | Non-Final OA | Apr 06, 2023 |
| 18026101 | METHODS FOR THE PRODUCTION OF GENOME EDITED PLANTS | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. | MCWILLIAMS, KELSEY LYNN | 1663 | Final Rejection | Mar 13, 2023 |
| 18100505 | PHARMACEUTICAL COMPOSITIONS OF MYCOPHENOLIC ACID AND/OR BETAMETHASONE FOR THE TREATMENT OF OCULAR DISORDERS | Surface Ophthalmics, Inc. | HUANG, GIGI GEORGIANA | 1613 | Non-Final OA | Jan 23, 2023 |
| 17827584 | COMPOSITIONS AND METHODS FOR TREATING NERVOUS SYSTEM INJURIES | Sanford Burnham Prebys Medical Discovery Institute | BRADLEY, CHRISTINA | 1654 | Final Rejection | May 27, 2022 |
| 17582627 | OPHTHALMIC PHARMACEUTICAL COMPOSITIONS AND METHODS FOR TREATING OCULAR SURFACE DISEASE | Surface Ophthalmics, Inc. | HUANG, GIGI GEORGIANA | 1613 | Final Rejection | Jan 24, 2022 |
| 17413181 | NUCLEIC ACID AMPLIFICATION AND IDENTIFICATION METHOD | Lexogen GmbH | GIAMMONA, FRANCESCA FILIPPA | 1681 | Non-Final OA | Jun 11, 2021 |
IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial